GoHealth (NASDAQ: GOCO) discloses Q3 2025 quarterly results press release

Rhea-AI Filing Summary

GoHealth, Inc. filed a current report to let investors know it has released its latest quarterly financial results. On November 13, 2025, the company issued a press release announcing results for the quarter ended September 30, 2025, and furnished that press release as Exhibit 99.1 to this report. The company notes that this earnings information is being furnished rather than filed, which means it is not automatically subject to certain Exchange Act liabilities or incorporated into other securities filings unless specifically referenced.

FALSE000180822000018082202025-11-132025-11-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 13, 2025

_________________________

GoHealth, Inc.

(Exact name of registrant as specified in its charter)

_________________________

Delaware			001-39390			85-0563805
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

222 W Merchandise Mart Plaza, Suite 1750									60654
Chicago,			Illinois
(Address of principal executive offices)									(Zip Code)

(312) 386-8200

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

_________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, $0.0001 par value per share

GOCO

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On November 13, 2025, the Company issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished pursuant to this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

The following exhibits are included herewith:

Exhibit Number						Description
99.1						Press Release issued by GoHealth, Inc. on November 13, 2025.
104						Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						GOHEALTH, INC.
Date:			November 13, 2025			By:			/s/ Brendan Shanahan
									Brendan Shanahan Chief Financial Officer (Principal Financial Officer)

FAQ

What did GoHealth (GOCO) report in this 8-K?

GoHealth reported that it issued a press release on November 13, 2025 announcing its financial results for the quarter ended September 30, 2025, which is furnished as Exhibit 99.1.

Which period do the latest GoHealth (GOCO) results cover?

The announced financial results relate to GoHealth’s quarter ended September 30, 2025.

How did GoHealth provide its Q3 2025 financial results?

GoHealth provided its quarterly financial results through a press release dated November 13, 2025, which is attached to the report as Exhibit 99.1.

Is GoHealth’s earnings press release considered filed with the SEC?

No. GoHealth states that the information under Item 2.02 and Exhibit 99.1 is furnished, not filed, and is not automatically subject to Section 18 liabilities or incorporated into other filings unless specifically referenced.

Who signed GoHealth’s November 13, 2025 report?

The report was signed on behalf of GoHealth, Inc. by Brendan Shanahan, Chief Financial Officer and principal financial officer.

What exhibits are included with this GoHealth (GOCO) 8-K?

The report includes Exhibit 99.1, the press release dated November 13, 2025, and Exhibit 104, the cover page interactive data file in inline XBRL format.